What to Expect in Month 3 Nausea improvement: Drops from constant/frequent to occasional/rare for most patients Energy returns: As your body adjusts to new eating patterns and medication Appetite normalization: Still suppressed (therapeutic effect) but more predictable Weight loss becomes visible: Average 8-10% by week 12, friends and family notice Confidence builds: Youve survived the worst, know you can continue 4 Strategies for Month 3 11
Bununla birlikte, her ilata olduu gibi GLP-1 tedavisi srasnda da baz yan etkiler grlebilmektedir
In some cases, blood tests are needed
Researchers quickly noticed that this peptide didnt just function in the stomach
Overview of Parkinsons Disease Parkinsons is a neurodegenerative movement disorder whose symptoms progressively worsen over time
DIABETIC PATIENTS TAKING GLP-1S MAY FACE INCREASED RISK OF EYE DISEASE, STUDY SUGGESTS While individuals with type 2 diabetes on GLP-1s showed a modestly increased risk of diabetic retinopathy, the researchers concluded that fewer patients experienced sight-threatening complications from the disease
